Portage Biotech Stock (NASDAQ: PRTG) stock price, news, charts, stock research, profile.
You can purchase shares of Portage Biotech (NASDAQ:PRTG) through any online brokerage.
Other companies in Portage Biotech’s space includes: Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Can Fite Biofarma (AMEX:CANF), Indaptus Therapeutics (NASDAQ:INDP) and TransCode Therapeutics (NASDAQ:RNAZ).
Portage Biotech has a consensus price target of $14.50.
The stock price for Portage Biotech (NASDAQ: PRTG) is $4.75 last updated February 19, 2025 at 3:32 PM EST.
There are no upcoming dividends for Portage Biotech.
Portage Biotech’s Q3 earnings are confirmed for Monday, March 3, 2025.
There is no upcoming split for Portage Biotech.
Portage Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.